Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 3/20 | 0.46 |
| ▸ | MMP2 | P08253 | 2/20 | 0.46 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | MMP14 | P50281 | 2/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP7 | P09237 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6323381 | 0.94 | MMP3 (0.51) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL20325506 | 0.83 | FFAR4 (0.44) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL930312 | 0.83 | PKM (0.58) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL9034923 | 0.81 | PTGS2 (0.55) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL13368922 | 0.80 | ALDH1A1 (0.38) | FFAR4ALDH1A3MMP3MMP2MMP9 | |
| SCHEMBL11154024 | 0.79 | KMT2A (0.52) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL13588841 | 0.79 | FFAR4 (0.50) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL29282758 | 0.79 | FFAR4 (0.50) | FFAR4ALDH1A3KMT2AMMP3MMP2 | |
| SCHEMBL189284 | 0.79 | ALDH1A1 (0.59) | FFAR4ALDH1A3PARP10ALDH1A1CA12 | |
| SCHEMBL856562 | 0.79 | TRPV4 (0.46) | KMT2AALDH1A1HSD17B10TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119425423-A | Positively charged composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-118047699-A | Preparation method of 4-isopropoxy benzenesulfonyl chloride | 武威广达科技有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-10584202-B2 | Photovoltaic element | TORAY INDUSTRIES, INC (JP) | 2020-03-10 | — | — | US | claimed |
| EP-3133659-B1 | METHOD FOR FORMING AN ELECTRON EXTRACTION LAYER | TORAY INDUSTRIES (JP) | 2019-05-22 | — | — | EP | claimed |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CHEMOCENTRYX, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| CN-121779283-A | Process for synthesizing 4-isopropoxy benzenesulfonyl chloride | 大连双硼医药化工有限公司 | 2026-04-03 | — | — | CN | disclosed |
| CN-121779283-A | Process for synthesizing 4-isopropoxy benzenesulfonyl chloride | 大连双硼医药化工有限公司 | 2026-04-03 | — | — | CN | disclosed |
| US-12570632-B2 | Indole derivatives and uses thereof for treating a cancer | UNIVERSITE CLAUDE BERNARD LYON 1 (FR) | 2026-03-10 | — | — | US | disclosed |
| US-20250170104-A1 | INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2025-05-29 | — | — | US | disclosed |
| CN-119425423-A | Positively charged composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4486452-A1 | INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LASSS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2025-01-08 | — | — | EP | disclosed |
| EP-4175718-B1 | INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER | UNIV CLAUDE BERNARD LYON (FR) | 2024-10-02 | — | — | EP | disclosed |
| US-20050038246-A1 | PPAR active compounds | PLEXXIKON, INC. | 2005-02-17 | — | — | US | disclosed |
| WO-2005009958-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON, INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| US-20040171654-A1 | Aryl sulfonamides | CHEMOCENTRYX, INC. | 2004-09-02 | — | — | US | disclosed |
| WO-2004046092-A2 | ARYL SULFONAMIDES | CHEMOCENTRYX (US) | 2004-06-03 | — | — | WO | disclosed |
| EP-0222343-B1 | RECORDING MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-11 | — | — | EP | disclosed |
| US-4874894-A | Process for the production of benzenesulfonamides | HILTON DAVIS CO. (US) | 1989-10-17 | — | — | US | disclosed |
| US-4792542-A | CONTAINING AN AROMATIC SULFIDE | FUJI PHOTO FILM CO., LTD. (JP) | 1988-12-20 | — | — | US | disclosed |
| EP-0222343-A2 | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050038246-A1 | PPAR active compounds | PPARG, PPARD, PPARA | FFAR4 29/4885ALDH1A3 1706/4885KMT2A 3773/4885 |
| US-12570632-B2 | Indole derivatives and uses thereof for treating a cancer | CKS2, CSNK2A3, CSNK1A1L | FFAR4 2969/4885ALDH1A3 3484/4885KMT2A 1423/4885 |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CCR1, CCR9, CCR8 | FFAR4 227/4885ALDH1A3 3345/4885KMT2A 2332/4885 |
| US-20250170104-A1 | INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß | LTA, SERPINB1, LAS1L | FFAR4 2314/4885ALDH1A3 4299/4885KMT2A 4683/4885 |
| US-20040171654-A1 | Aryl sulfonamides | CCR9, CCR1, CCR2 | FFAR4 216/4885ALDH1A3 3299/4885KMT2A 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.